|
1.
|
Tarnawski A, Ahluwalia A and Jones MK:
Gastric cytoprotection beyond prostaglandins: Cellular and
molecular mechanisms of gastroprotective and ulcer healing actions
of antacids. Curr Pharm Des. 19:126–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Lau JY, Barkun A, Fan DM, Kuipers EJ, Yang
YS and Chan FK: Challenges in the management of acute peptic ulcer
bleeding. Lancet. 381:2033–2043. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM,
Park YS and Kim N: Characteristics of gastric cancer in peptic
ulcer patients with Helicobacter pylori infection. World J
Gastroenterol. 21:4954–4960. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Taş İ, Ülger BV, Önder A, Kapan M and
Bozdağ Z: Risk factors influencing morbidity and mortality in
perforated peptic ulcer disease. Ulus Cerrahi Derg. 31:20–25.
2014.PubMed/NCBI
|
|
5.
|
Malfertheiner P: Helicobacter
pylori infection-management from a European perspective. Dig
Dis. 32:275–280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Wallace JL, Syer S, Denou E, de Palma G,
Vong L, McKnight W, Jury J, Bolla M, Bercik P, Collins SM, et al:
Proton pump inhibitors exacerbate NSAID-induced small intestinal
injury by inducing dysbiosis. Gastroenterology. 141:1314–1322.e5.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Karam SM and Forte JG: Inhibiting gastric
H(+)-K(+)-ATPase activity by omeprazole promotes degeneration and
production of parietal cells. Am J Physiol. 266:G745–G758.
1994.PubMed/NCBI
|
|
8.
|
Ghotaslou R, Leylabadlo HE and Asl YM:
Prevalence of antibiotic resistance in Helicobacter pylori:
A recent literature review. World J Methodol. 5:164–174. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Howden CW, Chey WD and Vakil NB: Clinical
rationale for confirmation testing after treatment of
Helicobacter pylori infection: Implications of rising
antibiotic resistance. Gastroenterol Hepatol (NY). 10(7 Suppl 3):
S1–S19. 2014.
|
|
10.
|
Tarnawski A, Hollander D, Krause WJ,
Dabros W, Stachura J and Gergely H: ‘Healed’ experimental gastric
ulcers remain histologically and ultrastructurally abnormal. J Clin
Gastroenterol. 12(Suppl 1): S139–S147. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Watanabe T, Higuchi K, Tominaga K,
Fujiwara Y and Arakawa T: Acid regulates inflammatory response in a
rat model of induction of gastric ulcer recurrence by interleukin
1beta. Gut. 48:774–781. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Arakawa T, Watanabe T, Tanigawa T,
Tominaga K, Fujiwara Y and Morimoto K: Quality of ulcer healing in
gastrointestinal tract: Its pathophysiology and clinical relevance.
World J Gastroenterol. 18:4811–4822. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Groenen MJ, Kuipers EJ, Hansen BE and
Ouwendijk RJ: Incidence of duodenal ulcers and gastric ulcers in a
Western population: Back to where it started. Can J Gastroenterol.
23:604–608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Sung JJ, Kuipers EJ and El-Serag HB:
Systematic review: The global incidence and prevalence of peptic
ulcer disease. Aliment Pharmacol Ther. 29:938–946. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Fujino S, Suzuki Y and Tanaka T:
Cost-benefit analysis of medicinal treatment for gastric ulcers.
Long-term model including healing and recurrence. Health Policy.
5:45–72. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Malfertheiner P, Chan FK and McColl KE:
Peptic ulcer disease. Lancet. 374:1449–1461. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Hirayama F, Takagi S, Kusuhara H, Iwao E,
Yokoyama Y and Ikeda Y: Induction of gastric ulcer and intestinal
metaplasia in mongolian gerbils infected with Helicobacter
pylori. J Gastroenterol. 31:755–757. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Wang GZ, Huang GP, Yin GL, Zhou G, Guo CJ,
Xie CG, Jia BB and Wang JF: Aspirin can elicit the recurrence of
gastric ulcer induced with acetic acid in rats. Cell Physiol
Biochem. 20:205–212. 2007.PubMed/NCBI
|
|
19.
|
Hammadi M, Adi M, John R, Khoder GA and
Karam SM: Dysregulation of gastric H,K-ATPase by cigarette smoke
extract. World J Gastroenterol. 15:4016–4022. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Tarnawski AS: Cellular and molecular
mechanisms of gastrointestinal ulcer healing. Dig Dis Sci. 50(Suppl
1): S24–S33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Tarnawski A, Szabo IL, Husain SS and
Soreghan B: Regeneration of gastric mucosa during ulcer healing is
triggered by growth factors and signal transduction pathways. J
Physiol Paris. 95:337–344. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Tarnawski AS and Ahluwalia A: Molecular
mechanisms of epithelial regeneration and neovascularization during
healing of gastric and esophageal ulcers. Curr Med Chem. 19:16–27.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Okamoto R, Yajima T, Yamazaki M, Kanai T,
Mukai M, Okamoto S, Ikeda Y, Hibi T, Inazawa J and Watanabe M:
Damaged epithelia regenerated by bone marrow-derived cells in the
human gastrointestinal tract. Nat Med. 8:1011–1017. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Karam SM: Lineage commitment and
maturation of epithelial cells in the gut. Front Biosci.
4:D286–D298. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Helander HF and Poorkhalkali N: Parietal
cell density during gastric ulcer healing in the rat. Scand J
Gastroenterol. 39:20–26. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Farrell JJ, Taupin D, Koh TJ, Chen D, Zhao
CM, Podolsky DK and Wang TC: TFF2/SP-deficient mice show decreased
gastric proliferation, increased acid secretion, and increased
susceptibility to NSAID injury. J Clin Invest. 109:193–204. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Liu L, Chiu PW, Lam PK, Poon CC, Lam CC,
Ng EK and Lai PB: Effect of local injection of mesenchymal stem
cells on healing of sutured gastric perforation in an experimental
model. Br J Surg. 102:e158–e168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Chang Q, Yan L, Wang CZ, Zhang WH, Hu YZ
and Wu BY: In vivo transplantation of bone marrow mesenchymal stem
cells accelerates repair of injured gastric mucosa in rats. Chin
Med J (Engl). 125:1169–1174. 2012.PubMed/NCBI
|
|
29.
|
Maemura T, Shin M and Kinoshita M: Tissue
engineering of the stomach. J Surg Res. 183:285–295. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Sato T and Clevers H: SnapShot: Growing
organoids from stem cells. Cell. 161:1700–1700.e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Pulikkot S, Greish YE, Mourad AH and Karam
SM: Establishment of a three-dimensional culture system of gastric
stem cells supporting mucous cell differentiation using
microfibrous polycaprolactone scaffolds. Cell Prolif. 47:553–563.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Elliott SN, Buret A, McKnight W, Miller MJ
and Wallace JL: Bacteria rapidly colonize and modulate healing of
gastric ulcers in rats. Am J Physiol. 275:G425–G432.
1998.PubMed/NCBI
|
|
33.
|
Podolsky SH: Metchnikoff and the
microbiome. Lancet. 380:1810–1811. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lilly DM and Stillwell RH: Probiotics:
Growth-promoting factors produced by microorganisms. Science.
147:747–748. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Hill C, Guarner F, Reid G, Gibson GR,
Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S,
et al: Expert consensus document. The International Scientific
Association for Probiotics and Prebiotics consensus statement on
the scope and appropriate use of the term probiotic. Nat Rev
Gastroenterol Hepatol. 11:506–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Wallace TC, Guarner F, Madsen K, Cabana
MD, Gibson G, Hentges E and Sanders ME: Human gut microbiota and
its relationship to health and disease. Nutr Rev. 69:392–403. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Bezkorovainy A: Probiotics: Determinants
of survival and growth in the gut. AmJ Clin Nutr. 73(Suppl 2):
S399–S405. 2001.
|
|
38.
|
Isolauri E, Sütas Y, Kankaanpää P,
Arvilommi H and Salminen S: Probiotics: Effects on immunity. Am J
Clin Nutr. 73(Suppl 2): S444–S450. 2001.
|
|
39.
|
Hong WS, Chen YP and Chen MJ: The
antiallergic effect of kefir lactobacilli. J Food Sci.
75:H244–H253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Cain AM and Karpa KD: Clinical utility of
probiotics in inflammatory bowel disease. Altern Ther Health Med.
17:72–79. 2011.PubMed/NCBI
|
|
41.
|
Shyu PT, Oyong GG and Cabrera EC:
Cytotoxicity of probiotics from Philippine commercial dairy
products on cancer cells and the effect on expression of cfos and
cjun early apoptotic-promoting genes and interleukin-1β and tumor
necrosis factor-α proinflammatory cytokine genes. Biomed Res Int.
2014:4917402014. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Lam EK, Yu L, Wong HP, Wu WK, Shin VY, Tai
EK, So WH, Woo PC and Cho CH: Probiotic Lactobacillus
rhamnosus GG enhances gastric ulcer healing in rats. Eur J
Pharmacol. 565:171–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Uchida M and Kurakazu K: Yogurt containing
Lactobacillus gasseri OLL2716 exerts gastroprotective action
against acute gastric lesion and antral ulcer in rats. J Pharmacol
Sci. 96:84–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Uchida M, Shimizu K and Kurakazu K: Yogurt
containing Lactobacillus gasseri OLL 2716 (LG21 yogurt)
accelerated the healing of acetic acid-induced gastric ulcer in
rats. Biosci Biotechnol Biochem. 74:1891–1894. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Singh PK and Kaur IP: Synbiotic (probiotic
and ginger extract) loaded floating beads: A novel therapeutic
option in an experimental paradigm of gastric ulcer. J Pharm
Pharmacol. 64:207–217. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Singh PK, Deol PK and Kaur IP: Entrapment
of Lactobacillus acidophilus into alginate beads for the
effective treatment of cold restraint stress induced gastric ulcer.
Food Funct. 3:83–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Dharmani P, De Simone C and Chadee K: The
probiotic mixture VSL#3 accelerates gastric ulcer healing by
stimulating vascular endothelial growth factor. PLoS One.
8:586712013. View Article : Google Scholar
|
|
48.
|
Lam EK, Tai EK, Koo MW, Wong HP, Wu WK, Yu
L, So WH, Woo PC and Cho CH: Enhancement of gastric mucosal
integrity by Lactobacillus rhamnosus GG. Life Sci.
80:2128–2136. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Timmerman HM, Koning CJ, Mulder L,
Rombouts FM and Beynen AC: Monostrain, multistrain and multispecies
probiotics - A comparison of functionality and efficacy. Int J Food
Microbiol. 96:219–233. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Flatley EA, Wilde AM and Nailor MD:
Saccharomyces boulardii for the prevention of hospital onset
Clostridium difficile infection. J Gastrointestin Liver Dis.
24:21–24. 2015.PubMed/NCBI
|
|
51.
|
Girard P, Coppé MC, Pansart Y and
Gillardin JM: Gastroprotective effect of Saccharomyces
boulardii in a rat model of ibuprofen-induced gastric ulcer.
Pharmacology. 85:188–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Sakarya S and Gunay N: Saccharomyces
boulardii expresses neuraminidase activity selective for
α2,3-linked sialic acid that decreases Helicobacter pylori
adhesion to host cells. APMIS. 122:941–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Aragon G, Graham DB, Borum M and Doman DB:
Probiotic therapy for irritable bowel syndrome. Gastroenterol
Hepatol (NY). 6:39–44. 2010.
|
|
54.
|
Brenner DM, Moeller MJ, Chey WD and
Schoenfeld PS: The utility of probiotics in the treatment of
irritable bowel syndrome: A systematic review. Am J Gastroenterol.
104:1033–1050. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Moayyedi P, Ford AC, Talley NJ, Cremonini
F, Foxx-Orenstein AE, Brandt LJ and Quigley EM: The efficacy of
probiotics in the treatment of irritable bowel syndrome: A
systematic review. Gut. 59:325–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Ki Cha B, Mun Jung S, Hwan Choi C, Song
ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS
and Seo JG: The effect of a multispecies probiotic mixture on the
symptoms and fecal microbiota in diarrhea-dominant irritable bowel
syndrome: A randomized, double-blind, placebo-controlled trial. J
Clin Gastroenterol. 46:220–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Lyra A, Krogius-Kurikka L, Nikkilä J,
Malinen E, Kajander K, Kurikka K, Korpela R and Palva A: Effect of
a multispecies probiotic supplement on quantity of irritable bowel
syndrome-related intestinal microbial phylotypes. BMC
Gastroenterol. 10:1102010. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Fuochi V, Petronio GP, Lissandrello E and
Furneri PM: Evaluation of resistance to low pH and bile salts of
human Lactobacillus spp. isolates. Int J Immunopathol
Pharmacol. 28:426–433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Pochart P, Marteau P, Bouhnik Y, Goderel
I, Bourlioux P and Rambaud JC: Survival of bifidobacteria ingested
via fermented milk during their passage through the human small
intestine: An in vivo study using intestinal perfusion. Am J Clin
Nutr. 55:78–80. 1992.PubMed/NCBI
|
|
60.
|
Lankaputhra WEV and Shah NP: Survival of
Lactobacillus acidophilus and Bifidobacterium in the
presence of acid and bile salts. Cult Dairy Prod J. 30:2–7.
1995.
|
|
61.
|
Costello M: Probiotic foods. Foodpro-93:
International Food Processing Machinery and Technology Exhibition
and Conference (Australia). Sydney Convention & Exhibition
Centre. July 12–14–1993.
|
|
62.
|
Clark PA, Cotton LN and Martin JH:
Selection of Bifidobacterium spp. for use as dietary
adjuncts in cultured dairy foods: II. Tolerance to simulated pH of
human stomachs. Cult Dairy Prod J. 28:11–14. 1993.
|
|
63.
|
Jacobsen CN, Rosenfeldt Nielsen V, Hayford
AE, Møller PL, Michaelsen KF, Paerregaard A, Sandström B, Tvede M
and Jakobsen M: Screening of probiotic activities of forty-seven
strains of Lactobacillus spp. by in vitro techniques and
evaluation of the colonization ability of five selected strains in
humans. Appl Environ Microbiol. 11:4949–4956. 1999.
|
|
64.
|
Lick S, Drescher K and Heller JK: Survival
of Lactobacillus delbrueckii subsp. bulgaricus and
Streptococcus thermophilus in the terminal ileum of
fistulated Göttingen minipigs. Appl Environ Microbiol.
67:4137–4143. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Cotter PD and Hill C: Surviving the acid
test: Responses of gram-positive bacteria to low pH. Microbiol Mol
Biol Rev. 67:429–453. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
66.
|
Fortier LC, Tourdot-Maréchal R, Diviès C,
Lee BH and Guzzo J: Induction of Oenococcus oeni
H+-ATPase activity and mRNA transcription under acidic
conditions. FEMS Microbiol Lett. 222:165–169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Rius N, Solé M, Francis A and Lorén JG:
Buffering capacity and membrane H+ conductance of lactic
acid bacteria. FEMS Microbiol Lett. 120:291–296. 1994. View Article : Google Scholar
|
|
68.
|
Charalampopoulos D, Pandiella SS and Webb
C: Evaluation of the effect of malt, wheat and barley extracts on
the viability of potentially probiotic lactic acid bacteria under
acidic conditions. Int J Food Microbiol. 82:133–141. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Corcoran BM, Stanton C, Fitzgerald GF and
Ross RP: Survival of probiotic lactobacilli in acidic environments
is enhanced in the presence of metabolizable sugars. Appl Environ
Microbiol. 71:3060–3067. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
70.
|
Haghshenas B, Abdullah N, Nami Y, Radiah
D, Rosli R and Yari Khosroushahi A: Microencapsulation of probiotic
bacteria Lactobacillus plantarum 15HN using
alginate-psyllium-fenugreek polymeric blends. J Appl Microbiol.
118:1048–1057. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71.
|
Chen S, Zhao Q, Ferguson LR, Shu Q, Weir I
and Garg S: Development of a novel probiotic delivery system based
on microencapsulation with protectants. Appl Microbiol Biotechnol.
93:1447–1457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
Kailasapathy K: Microencapsulation of
probiotic bacteria: Technology and potential applications. Curr
Issues Intest Microbiol. 3:39–48. 2002.PubMed/NCBI
|
|
73.
|
Villena MJ, Lara-Villoslada F, Martínez MA
and Hernández ME: Development of gastro-resistant tablets for the
protection and intestinal delivery of Lactobacillus
fermentum CECT 5716. Int J Pharm. 487:314–319. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74.
|
Mei L, He F, Zhou RQ, Wu CD, Liang R, Xie
R, Ju XJ, Wang W and Chu LY: Novel intestinal-targeted
Ca-alginate-based carrier for pH-responsive protection and release
of lactic acid bacteria. ACS Appl Mater Interfaces. 6:5962–5970.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
75.
|
Zhao Q, Lee SJ, Mutukumira AN, Maddox I
and Shu Q: Viability and delivery of immobilised Lactobacillus
reuteri DPC16 within calcium alginate gel systems during
sequential passage through simulated gastrointestinal fluids. Benef
Microbes. 2:129–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76.
|
Adams CA: The probiotic paradox: Live and
dead cells are biological response modifiers. Nutr Res Rev.
23:37–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77.
|
Sashihara T, Sueki N and Ikegami S: An
analysis of the effectiveness of heat-killed lactic acid bacteria
in alleviating allergic diseases. J Dairy Sci. 89:2846–2855. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
78.
|
Zhang L, Nan L, Caicedo R and Neu J: Alive
and dead Lactobacillus rhamnosus GG decrease tumor necrosis
factor-alpha-induced interleukin-8 production in Caco-2 cells. J
Nutr. 135:1752–1756. 2005.PubMed/NCBI
|
|
79.
|
Taverniti V and Guglielmetti S: The
immunomodulatory properties of probiotic microorganisms beyond
their viability (ghost probiotics: Proposal of paraprobiotic
concept). Genes Nutr. 6:261–274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
80.
|
Sakai Y, Tsukahara T, Bukawa W, Matsubara
N and Ushida K: Cell preparation of Enterococcus faecalis
strain EC-12 prevents vancomycin-resistant enterococci colonization
in the cecum of newly hatched chicks. Poult Sci. 85:273–277. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
81.
|
Marin ML, Lee JH, Murtha J, Ustunol Z and
Pestka JJ: Differential cytokine production in clonal macrophage
and T-cell lines cultured with bifidobacteria. J Dairy Sci.
80:2713–2720. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
82.
|
Wagner RD, Pierson C, Warner T, Dohnalek
M, Hilty M and Balish E: Probiotic effects of feeding heat-killed
Lactobacillus acidophilus and Lactobacillus casei to
Candida albicans-colonized immunodeficient mice. J Food
Prot. 63:638–644. 2000.PubMed/NCBI
|
|
83.
|
Rachmilewitz D, Katakura K, Karmeli F,
Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J,
Takabayashi K and Raz E: Toll-like receptor 9 signaling mediates
the anti-inflammatory effects of probiotics in murine experimental
colitis. Gastroenterology. 126:520–528. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
84.
|
Orlando A, Refolo MG, Messa C, Amati L,
Lavermicocca P, Guerra V and Russo F: Antiproliferative and
proapoptotic effects of viable or heat-killed Lactobacillus
paracasei IMPC2.1 and Lactobacillus rhamnosus GG in
HGC-27 gastric and DLD-1 colon cell lines. Nutr Cancer.
64:1103–1111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
85.
|
Sanders ME, Guarner F, Guerrant R, Holt
PR, Quigley EM, Sartor RB, Sherman PM and Mayer EA: An update on
the use and investigation of probiotics in health and disease. Gut.
62:787–796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
86.
|
Marchesi JR, Adams DH, Fava F, Hermes GD,
Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM,
et al: The gut microbiota and host health: A new clinical frontier.
Gut. 65:330–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
87.
|
Kumar M, Nagpal R, Kumar R, Hemalatha R,
Verma V, Kumar A, Chakraborty C, Singh B, Marotta F, Jain S and
Yadav H: Cholesterol-lowering probiotics as potential
biotherapeutics for metabolic diseases. Exp Diabetes Res.
2012:9029172012. View Article : Google Scholar : PubMed/NCBI
|
|
88.
|
Tsai TY, Chen LY and Pan TM: Effect of
probiotic-fermented, genetically modified soy milk on
hypercholesterolemia in hamsters. J Microbiol Immunol Infect.
47:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89.
|
Pereira DI and Gibson GR: Cholesterol
assimilation by lactic acid bacteria and bifidobacteria isolated
from the human gut. Appl Environ Microbiol. 68:4689–4693. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
90.
|
Kadooka Y, Sato M, Imaizumi K, Ogawa A,
Ikuyama K, Akai Y, Okano M, Kagoshima M and Tsuchida T: Regulation
of abdominal adiposity by probiotics (Lactobacillus gasseri
SBT2055) in adults with obese tendencies in a randomized controlled
trial. Eur J Clin Nutr. 64:636–643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
91.
|
Yoda K, Sun X, Kawase M, Kubota A,
Miyazawa K, Harata G, Hosoda M, Hiramatsu M, He F and Zemel MB: A
combination of probiotics and whey proteins enhances anti-obesity
effects of calcium and dairy products during nutritional energy
restriction in aP2-agouti transgenic mice. Br J Nutr.
113:1689–1696. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
92.
|
Kim SH, Huh CS, Choi ID, Jeong JW, Ku HK,
Ra JH, Kim TY, Kim GB, Sim JH and Ahn YT: The anti-diabetic
activity of Bifidobacterium lactis HY8101 in vitro and in
vivo. J Appl Microbiol. 117:834–845. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
93.
|
Moroti C, Souza Magri LF, de Rezende Costa
M, Cavallini DC and Sivieri K: Effect of the consumption of a new
symbiotic shake on glycemia and cholesterol levels in elderly
people with type 2 diabetes mellitus. Lipids Health Dis. 11:292012.
View Article : Google Scholar : PubMed/NCBI
|
|
94.
|
Huang Y, Wang J, Quan G, Wang X, Yang L
and Zhong L: Lactobacillus acidophilus ATCC 4356 prevents
atherosclerosis via inhibition of intestinal cholesterol absorption
in apolipoprotein E-knockout mice. Appl Environ Microbiol.
80:7496–7504. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
95.
|
Aihara K, Kajimoto O, Hirata H, Takahashi
R and Nakamura Y: Effect of powdered fermented milk with
Lactobacillus helveticus on subjects with high-normal blood
pressure or mild hypertension. J Am Coll Nutr. 24:257–265. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
96.
|
Rashid SK, Idris-Khodja N, Auger C,
Alhosin M, Boehm N, Oswald-Mammosser M and Schini-Kerth VB:
Probiotics (VSL#3) prevent endothelial dysfunction in rats with
portal hypertension: Role of the angiotensin system. PLoS One.
9:e974582014. View Article : Google Scholar : PubMed/NCBI
|
|
97.
|
Fotiadis CI, Stoidis CN, Spyropoulos BG
and Zografos ED: Role of probiotics, prebiotics and synbiotics in
chemoprevention for colorectal cancer. World J Gastroenterol.
14:6453–6457. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
98.
|
Sobhani I, Amiot A, Le Baleur Y, Levy M,
Auriault ML, Van Nhieu JT and Delchier JC: Microbial dysbiosis and
colon carcinogenesis: Could colon cancer be considered a
bacteria-related disease? Therap Adv Gastroenterol. 6:215–229.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
99.
|
Zhang M, Fan X, Fang B, Zhu C, Zhu J and
Ren F: Effects of Lactobacillus salivarius Ren on cancer
prevention and intestinal microbiota in
1,2-dimethylhydrazine-induced rat model. J Microbiol. 53:398–405.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
100.
|
Chen ZF, Ai LY, Wang JL, Ren LL, Yu YN, Xu
J, Chen HY, Yu J, Li M, Qin WX, et al: Probiotics Clostridium
butyricum and Bacillus subtilis ameliorate intestinal
tumorigenesis. Future Microbiol. 10:1433–1445. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
101.
|
Russo F, Linsalata M and Orlando A:
Probiotics against neoplastic transformation of gastric mucosa:
Effects on cell proliferation and polyamine metabolism. World J
Gastroenterol. 20:13258–13272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
102.
|
Cousin FJ, Jouan-Lanhouet S,
Dimanche-Boitrel MT, Corcos L and Jan G: Milk fermented by
Propionibacterium freudenreichii induces apoptosis of HGT-1
human gastric cancer cells. PLoS One. 7:e318922012. View Article : Google Scholar : PubMed/NCBI
|
|
103.
|
Linsalata M, Cavallini A, Messa C, Orlando
A, Refolo MG and Russo F: Lactobacillus rhamnosus GG
influences polyamine metabolism in HGC-27 gastric cancer cell line:
A strategy toward nutritional approach to chemoprevention of
gastric cancer. Curr Pharm Des. 16:847–853. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
104.
|
Haghshenas B, Abdullah N, Nami Y, Radiah
D, Rosli R and Khosroushahi AY: Different effects of two
newly-isolated probiotic Lactobacillus plantarum 15HN and
Lactococcus lactis subsp. Lactis 44Lac strains from
traditional dairy products on cancer cell lines. Anaerobe.
30:51–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
105.
|
Chitapanarux I, Chitapanarux T, Traisathit
P, Kudumpee S, Tharavichitkul E and Lorvidhaya V: Randomized
controlled trial of live Lactobacillus acidophilus plus
Bifidobacterium bifidum in prophylaxis of diarrhea during
radiotherapy in cervical cancer patients. Radiat Oncol. 5:312010.
View Article : Google Scholar : PubMed/NCBI
|
|
106.
|
Osterlund P, Ruotsalainen T, Korpela R,
Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I and Joensuu H:
Lactobacillus supplementation for diarrhoea related to
chemotherapy of colorectal cancer: A randomised study. Br J Cancer.
97:1028–1034. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
107.
|
Crouzet L, Rigottier-Gois L and Serror P:
Potential use of probiotic and commensal bacteria as non-antibiotic
strategies against vancomycin-resistant enterococci. FEMS Microbiol
Lett. 362:fnv0122015. View Article : Google Scholar : PubMed/NCBI
|
|
108.
|
Gill EE, Franco OL and Hancock RE:
Antibiotic adjuvants: Diverse strategies for controlling
drug-resistant pathogens. Chem Biol Drug Des. 85:56–78. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
109.
|
Cano-Garrido O, Seras-Franzoso J and
Garcia-Fruitós E: Lactic acid bacteria: Reviewing the potential of
a promising delivery live vector for biomedical purposes. Microb
Cell Fact. 14:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
110.
|
Mohamadzadeh M and Owen JL: Reprogramming
intestinal immunity is the answer to induced pathogenic
inflammation. Immunotherapy. 3:1415–1417. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
111.
|
Wells JM and Mercenier A: Mucosal delivery
of therapeutic and prophylactic molecules using lactic acid
bacteria. Nat Rev Microbiol. 6:349–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
112.
|
Bermúdez-Humarán LG: Lactococcus
lactis as a live vector for mucosal delivery of therapeutic
proteins. Hum Vaccin. 5:264–267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
113.
|
Marelli B, Perez AR, Banchio C, de Mendoza
D and Magni C: Oral immunization with live Lactococcus
lactis expressing rotavirus VP8 subunit induces specific immune
response in mice. J Virol Methods. 175:28–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
114.
|
Konturek PC, Sliwowski Z, Koziel J,
Ptak-Belowska A, Burnat G, Brzozowski T and Konturek SJ: Probiotic
bacteria Escherichia coli strain Nissle 1917 attenuates
acute gastric lesions induced by stress. J Physiol Pharmacol.
60(Suppl 6): S41–S48. 2009.
|
|
115.
|
Spivak MIa, Lazarenko LM, Falalieieva TM,
Virchenko OV and Neporada KS: Prophylactic effect of probiotic
strains Bifidobacterium animalis VKL and VKB on
stress-induced lesions in the gastric mucosa of rats. Fiziol Zh.
59:23–30. 2013.(In Ukrainian). PubMed/NCBI
|
|
116.
|
Nagaoka M, Hashimoto S, Watanabe T,
Yokokura T and Mori Y: Anti-ulcer effects of lactic acid bacteria
and their cell wall polysaccharides. Biol Pharm Bull. 17:1012–1017.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
117.
|
Viggiano D, Ianiro G, Vanella G, Bibbò S,
Bruno G, Simeone G and Mele G: Gut barrier in health and disease:
Focus on childhood. Eur Rev Med Pharmacol Sci. 19:1077–1085.
2015.PubMed/NCBI
|
|
118.
|
Laine L, Takeuchi K and Tarnawski A:
Gastric mucosal defense and cytoprotection: Bench to bedside.
Gastroenterology. 135:41–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
119.
|
Takeeda M, Hayashi Y, Yamato M, Murakami M
and Takeuchi K: Roles of endogenous prostaglandins and
cyclooxygenase izoenzymes in mucosal defense of inflamed rat
stomach. J Physiol Pharmacol. 55:193–205. 2004.PubMed/NCBI
|
|
120.
|
Boirivant M and Strober W: The mechanism
of action of probiotics. Curr Opin Gastroenterol. 23:679–692. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
121.
|
Vieira AT, Teixeira MM and Martins FS: The
role of probiotics and prebiotics in inducing gut immunity. Front
Immunol. 4:4452013. View Article : Google Scholar : PubMed/NCBI
|
|
122.
|
Jones SE and Versalovic J: Probiotic
Lactobacillus reuteri biofilms produce antimicrobial and
anti-inflammatory factors. BMC Microbiol. 9:352009. View Article : Google Scholar : PubMed/NCBI
|
|
123.
|
Coman MM, Verdenelli MC, Cecchini C, Silvi
S, Orpianesi C, Boyko N and Cresci A: In vitro evaluation of
antimicrobial activity of Lactobacillus rhamnosus IMC
501®, Lactobacillus paracasei IMC 502®
and SYNBIO® against pathogens. J Appl Microbiol.
117:518–527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
124.
|
Bernet MF, Brassart D, Neeser JR and
Servin AL: Lactobacillus acidophilus LA 1 binds to cultured
human intestinal cell lines and inhibits cell attachment and cell
invasion by enterovirulent bacteria. Gut. 35:483–489. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
125.
|
Mukai T, Asasaka T, Sato E, Mori K,
Matsumoto M and Ohori H: Inhibition of binding of Helicobacter
pylori to the glycolipid receptors by probiotic
Lactobacillus reuteri. FEMS Immunol Med Microbiol.
32:105–110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
126.
|
Lin YP, Thibodeaux CH, Peña JA, Ferry GD
and Versalovic J: Probiotic Lactobacillus reuteri suppress
proinflammatory cytokines via c-Jun. Inflamm Bowel Dis.
14:1068–1083. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
127.
|
Takagi A, Matsuzaki T, Sato M, Nomoto K,
Morotomi M and Yokokura T: Enhancement of natural killer
cytotoxicity delayed murine carcinogenesis by a probiotic
microorganism. Carcinogenesis. 22:599–605. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
128.
|
Haller D, Bode C, Hammes WP, Pfeifer AM,
Schiffrin EJ and Blum S: Non-pathogenic bacteria elicit a
differential cytokine response by intestinal epithelial
cell/leucocyte co-cultures. Gut. 47:79–87. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
129.
|
Borchers AT, Selmi C, Meyers FJ, Keen CL
and Gershwin ME: Probiotics and immunity. J Gastroenterol.
44:26–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
130.
|
Madsen K, Cornish A, Soper P, McKaigney C,
Jijon H, Yachimec C, Doyle J, Jewell L and De Simone C: Probiotic
bacteria enhance murine and human intestinal epithelial barrier
function. Gastroenterology. 121:580–591. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
131.
|
Gotteland M, Cruchet S and Verbeke S:
Effect of Lactobacillus ingestion on the gastrointestinal mucosal
barrier alterations induced by indomethacin in humans. Aliment
Pharmacol Ther. 15:11–17. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
132.
|
Rao RK and Samak G: Protection and
Restitution of Gut Barrier by Probiotics: Nutritional and clinical
implications. Curr Nutr Food Sci. 9:99–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
133.
|
Gomi A, Harima-Mizusawa N, Shibahara-Sone
H, Kano M, Miyazaki K and Ishikawa F: Effect of Bifidobacterium
bifidum BF-1 on gastric protection and mucin production in an
acute gastric injury rat model. J Dairy Sci. 96:832–837. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
134.
|
Dai C, Zhao DH and Jiang M: VSL#3
probiotics regulate the intestinal epithelial barrier in vivo and
in vitro via the p38 and ERK signaling pathways. Int J Mol Med.
29:202–208. 2012.PubMed/NCBI
|
|
135.
|
Mennigen R, Nolte K, Rijcken E, Utech M,
Loeffler B, Senninger N and Bruewer M: Probiotic mixture VSL#3
protects the epithelial barrier by maintaining tight junction
protein expression and preventing apoptosis in a murine model of
colitis. Am J Physiol Gastrointest Liver Physiol. 296:G1140–G1149.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
136.
|
Wang FY, Liu JM, Luo HH, Liu AH and Jiang
Y: Potential protective effects of Clostridium butyricum on
experimental gastric ulcers in mice. World J Gastroenterol.
21:8340–8351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
137.
|
Virchenko OV, Falalyeyeva TM, Beregova TV,
Spivak MY, Lazarenko LM and Demchenko OM: Effects of mono-, poly-
and composite probiotics on the ulceration caused by restraint
stress. Fiziol Zh. 61:35–41. 2015.(In Ukrainian). PubMed/NCBI
|
|
138.
|
Virchenko OV, Falalyeyeva TM, Beregova TV
and Maryana SY: The multistrain probiotic enhances the healing
process of stress-induced lesions of the gastric mucosa of rats.
RJPBCS. 6:2492015.
|
|
139.
|
Wang JY, Yamasaki S, Takeuchi K and Okabe
S: Delayed healing of acetic acid-induced gastric ulcers in rats by
indomethacin. Gastroenterology. 96:393–402. 1989.PubMed/NCBI
|
|
140.
|
Santucci L, Fiorucci S, Di Matteo FM and
Morelli A: Role of tumor necrosis factor alpha release and
leukocyte margination in indomethacin-induced gastric injury in
rats. Gastroenterology. 108:393–401. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
141.
|
Yoshikawa T, Takano H, Naito Y, Oyamada H,
Ueda S and Kondo M: Augmentative effects of tumor necrosis
factor-alpha (human, natural type) on polymorphonuclear
leukocyte-derived superoxide generation induced by various
stimulants. Int J Immunopharmacol. 14:1391–1398. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
142.
|
Senol A, Işler M, Karahan AG, Kiliç GB,
Kuleaşan H, Gören I, Saritaş U, Kaya S, Cırış M, Aktürk O, et al:
Effect of probiotics on aspirin-induced gastric mucosal lesions.
Turk J Gastroenterol. 22:18–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
143.
|
Senol A, Isler M, Karahan AG, Kilic GB,
Kuleasan H, Kaya S, Keskin M, Goren I, Saritas U, Aridogan BC and
Delibas N: Preventive effect of probiotics and α-tocopherol on
ethanol-induced gastric mucosal injury in rats. J Med Food.
14:173–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
144.
|
Allen A and Pearson JP: Mucus
glycoproteins of the normal gastrointestinal tract. Eur J
Gastroenterol Hepatol. 5:193–199. 1993. View Article : Google Scholar
|
|
145.
|
Wong WM, Poulsom R and Wright NA: Trefoil
peptides. Gut. 44:890–895. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
146.
|
Phillipson M, Johansson ME, Henriksnäs J,
Petersson J, Gendler SJ, Sandler S, Persson AE, Hansson GC and Holm
L: The gastric mucus layers: Constituents and regulation of
accumulation. Am J Physiol Gastrointest Liver Physiol.
295:G806–G812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
147.
|
Corfield AP, Carroll D, Myerscough N and
Probert CS: Mucins in the gastrointestinal tract in health and
disease. Front Biosci. 6:D1321–D1357. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
148.
|
Singh PK and Hollingsworth MA: Cell surf
ace-associated mucins in signal transduction. Trends Cell Biol.
16:467–476. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
149.
|
Karam SM, Tomasetto C and Rio MC: Trefoil
factor 1 is required for the commitment programme of mouse oxyntic
epithelial progenitors. Gut. 53:1408–1415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
150.
|
Ren JL, Luo JY, Lu YP, Wang L and Shi HX:
Relationship between trefoil factor 1 expression and gastric mucosa
injuries and gastric cancer. World J Gastroenterol. 11:2674–2677.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
151.
|
Fu T, Kalbacher H and Hoffmann W: TFF1 is
differentially expressed in stationary and migratory rat gastric
epithelial cells (RGM-1) after in vitro wounding: Influence of TFF1
RNA interference on cell migration. Cell Physiol Biochem.
32:997–1010. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
152.
|
Atuma C, Strugala V, Allen A and Holm L:
The adherent gastrointestinal mucus gel layer: Thickness and
physical state in vivo. Am J Physiol Gastrointest Liver Physiol.
280:G922–G929. 2001.PubMed/NCBI
|
|
153.
|
Kaunitz JD: Barrier function of gastric
mucus. Keio J Med. 2:63–68. 1999. View Article : Google Scholar
|
|
154.
|
Mattar AF, Teitelbaum DH, Drongowski RA,
Yongyi F, Harmon CM and Coran AG: Probiotics up-regulate MUC-2
mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg
Int. 18:586–590. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
155.
|
Kim Y, Kim SH, Whang KY, Kim YJ and Oh S:
Inhibition of Escherichia coli O157:H7 attachment by
interactions between lactic acid bacteria and intestinal epithelial
cells. J Microbiol Biotechnol. 18:1278–1285. 2008.PubMed/NCBI
|
|
156.
|
Otte JM and Podolsky DK: Functional
modulation of enterocytes by gram-positive and gram-negative
microorganisms. Am J Physiol Gastrointest Liver Physiol.
286:G613–G626. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
157.
|
Caballero-Franco C, Keller K, De Simone C
and Chadee K: The VSL#3 probiotic formula induces mucin gene
expression and secretion in colonic epithelial cells. Am J Physiol
Gastrointest Liver Physiol. 292:G315–G322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
158.
|
Ouwehand AC, Salminen S, Tölkkö S, Roberts
P, Ovaska J and Salminen E: Resected human colonic tissue: New
model for characterizing adhesion of lactic acid bacteria. Clin
Diagn Lab Immunol. 9:184–186. 2002.PubMed/NCBI
|
|
159.
|
Nishiyama K, Nakamata K, Ueno S, Terao A,
Aryantini NP, Sujaya IN, Fukuda K, Urashima T, Yamamoto Y and Mukai
T: Adhesion properties of Lactobacillus rhamnosus
mucus-binding factor to mucin and extracellular matrix proteins.
Biosci Biotechnol Biochem. 79:271–279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
160.
|
Karam SM and Leblond CP: Dynamics of
epithelial cells in the corpus of the mouse stomach.
I.dentification of proliferative cell types and pinpointing of the
stem cell. Anat Rec. 236:259–279. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
161.
|
Karam SM, Straiton T, Hassan WM and
Leblond CP: Defining epithelial cell progenitors in the human
oxyntic mucosa. Stem Cells. 21:322–336. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
162.
|
Karam SM: A focus on parietal cells as a
renewing cell population. World J Gastroenterol. 16:538–546. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
163.
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
164.
|
Taketani Y, Kinugasa K, Kitajima R,
Nishiumi S, Ashida H, Nakamura H, Fujita T, Kanzaki K, Masutani H
and Yodoi J: Protective effects of oral administration of yeast
thioredoxin against gastric mucosal injury. Biosci Biotechnol
Biochem. 78:1221–1230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
165.
|
Schöttker B, Adamu MA, Weck MN and Brenner
H: Helicobacter pylori infection is strongly associated with
gastric and duodenal ulcers in a large prospective study. Clin
Gastroenterol Hepatol. 10:487–493.e1. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
166.
|
Cover TL and Blaser MJ: Helicobacter
pylori in health and disease. Gastroenterology. 136:1863–1873.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
167.
|
Vergara M, Catalán M, Gisbert JP and
Calvet X: Meta-analysis: Role of Helicobacter pylori
eradication in the prevention of peptic ulcer in NSAID users.
Aliment Pharmacol Ther. 21:1411–1418. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
168.
|
Malfertheiner P, Selgrad M and Bornschein
J: Helicobacter pylori: Clinical management. Curr Opin
Gastroenterol. 28:608–614. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
169.
|
Giorgio F, Principi M, De Francesco V,
Zullo A, Losurdo G, Di Leo A and Ierardi E: Primary clarithromycin
resistance to Helicobacter pylori: Is this the main reason
for triple therapy failure? World J Gastrointest Pathophysiol.
4:43–46. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
170.
|
Graham DY and Fischbach L: Helicobacter
pylori treatment in the era of increasing antibiotic
resistance. Gut. 59:1143–1153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
171.
|
Papastergiou V, Georgopoulos SD and
Karatapanis S: Treatment of Helicobacter pylori infection:
Meeting the challenge of antimicrobial resistance. World J
Gastroenterol. 20:9898–9911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
172.
|
Tongtawee T, Dechsukhum C, Leeanansaksiri
W, Kaewpitoon S, Kaewpitoon N, Loyd RA, Matrakool L and Panpimanmas
S: Improved Helicobacter pylori eradication rate of tailored
triple therapy by adding Lactobacillus delbrueckii and
Streptococcus thermophilus in northeast region of Thailand:
A prospective randomized controlled clinical trial. Gastroenterol
Res Pract. 2015:5180182015. View Article : Google Scholar : PubMed/NCBI
|
|
173.
|
Johnson-Henry KC, Mitchell DJ, Avitzur Y,
Galindo-Mata E, Jones NL and Sherman PM: Probiotics reduce
bacterial colonization and gastric inflammation in H.
pylori-infected mice. Dig Dis Sci. 49:1095–1102. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
174.
|
Sheu BS, Wu JJ, Lo CY, Wu HW, Chen JH, Lin
YS and Lin MD: Impact of supplement with Lactobacillus- and
Bifidobacterium-containing yogurt on triple therapy for
Helicobacter pylori eradication. Aliment Pharmacol Ther.
16:1669–1675. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
175.
|
Ushiyama A, Tanaka K, Aiba Y, Shiba T,
Takagi A, Mine T and Koga Y: Lactobacillus gasseri OLL2716
as a probiotic in clarithromycin-resistant Helicobacter
pylori infection. J Gastroenterol Hepatol. 18:986–991. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
176.
|
Chenoll E, Casinos B, Bataller E, Astals
P, Echevarría J, Iglesias JR, Balbarie P, Ramón D and Genovés S:
Novel probiotic Bifidobacterium bifidum CECT 7366 strain
active against the pathogenic bacterium Helicobacter pylori.
Appl Environ Microbiol. 77:1335–1343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
177.
|
Gotteland M and Cruchet S: Suppressive
effect of frequent ingestion of Lactobacillus johnsonii La1
on Helicobacter pylori colonization in asymptomatic
volunteers. J Antimicrob Chemother. 51:1317–1319. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
178.
|
Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa
T and Koga Y: Prevention of Helicobacter pylori infection by
lactobacilli in a gnotobiotic murine model. Gut. 41:49–55. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
179.
|
Lesbros-Pantoflickova D, Corthésy-Theulaz
I and Blum AL: Helicobacter pylori and probiotics. J Nutr.
137(3 Suppl 2): S812–S818. 2007.
|
|
180.
|
Ruggiero P: Use of probiotics in the fight
against Helicobacter pylori. World J Gastrointest
Pathophysiol. 5:384–391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
181.
|
Yang YJ and Sheu BS: Probiotics-containing
yogurts suppress Helicobacter pylori load and modify immune
response and intestinal microbiota in the Helicobacter
pylori-infected children. Helicobacter. 17:297–304. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
182.
|
Sgouras D, Maragkoudakis P, Petraki K,
Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G,
Tsakalidou E and Mentis A: In vitro and in vivo inhibition of
Helicobacter pylori by Lactobacillus casei strain
Shirota. Appl Environ Microbiol. 70:518–526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
183.
|
Aiba Y, Nakano Y, Koga Y, Takahashi K and
Komatsu Y: A highly acid-resistant novel strain of Lactobacillus
johnsonii No. 1088 has antibacterial activity, including that
against Helicobacter pylori, and inhibits gastrin-mediated
acid production in mice. Microbiologyopen. 4:465–474. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
184.
|
Isobe H, Nishiyama A, Takano T, Higuchi W,
Nakagawa S, Taneike I, Fukushima Y and Yamamoto T: Reduction of
overall Helicobacter pylori colonization levels in the
stomach of Mongolian gerbil by Lactobacillus johnsonii La1
(LC1) and its in vitro activities against H. pylori motility
and adherence. Biosci Biotechnol Biochem. 76:850–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
185.
|
Hsieh PS, Tsai YC, Chen YC, Teh SF, Ou CM
and King VA: Eradication of Helicobacter pylori infection by
the probiotic strains Lactobacillus johnsonii MH-68 and
L. salivarius ssp. salicinius AP-32. Helicobacter.
17:466–477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
186.
|
Chen X, Liu XM, Tian F, Zhang Q, Zhang HP,
Zhang H and Chen W: Antagonistic activities of lactobacilli against
Helicobacter pylori growth and infection in human gastric
epithelial cells. J Food Sci. 77:M9–M14. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
187.
|
Mack DR, Ahrne S, Hyde L, Wei S and
Hollingsworth MA: Extracellular MUC3 mucin secretion follows
adherence of Lactobacillus strains to intestinal epithelial
cells in vitro. Gut. 52:827–833. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
188.
|
Thiraworawong T, Spinler JK, Werawatganon
D, Klaikeaw N, Venable SF, Versalovic J and Tumwasorn S:
Anti-inflammatory properties of gastric-derived Lactobacillus
plantarum XB7 in the context of Helicobacter pylori
infection. Helicobacter. 19:144–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
189.
|
Hwang SW, Kim N, Kim JM, Huh CS, Ahn YT,
Park SH, Shin CM, Park JH, Lee MK, Nam RH, et al: Probiotic
suppression of the H. pylori-induced responses by conjugated
linoleic acids in a gastric epithelial cell line. Prostaglandins
Leukot Essent Fatty Acids. 86:225–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
190.
|
Kim JM, Kim JS, Kim YJ, Oh YK, Kim IY,
Chee YJ, Han JS and Jung HC: Conjugated linoleic acids produced by
Lactobacillus dissociates IKK-gamma and Hsp90 complex in
Helicobacter pylori-infected gastric epithelial cells. Lab
Invest. 88:541–552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
191.
|
Lee JS, Paek NS, Kwon OS and Hahm KB:
Anti-inflammatory actions of probiotics through activating
suppressor of cytokine signaling (SOCS) expression and signaling in
Helicobacter pylori infection: A novel mechanism. J
Gastroenterol Hepatol. 25:194–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
192.
|
Mehling H and Busjahn A: Non-viable
Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new
approach to Helicobacter pylori control in humans.
Nutrients. 5:3062–3073. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
193.
|
Holz C, Busjahn A, Mehling H, Arya S,
Boettner M, Habibi H and Lang C: Significant reduction in
Helicobacter pylori load in humans with non-viable
Lactobacillus reuteri DSM17648: A pilot study. Probiotics
Antimicrob Proteins. 7:91–100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
194.
|
Hauser G, Salkic N, Vukelic K, JajacKnez A
and Stimac D: Probiotics for standard triple Helicobacter
pylori eradication: A randomized, double-blind,
placebo-controlled trial. Medicine (Baltimore). 94:e6852015.
View Article : Google Scholar : PubMed/NCBI
|
|
195.
|
Francavilla R, Polimeno L, Demichina A,
Maurogiovanni G, Principi B, Scaccianoce G, Ierardi E, Russo F,
Riezzo G, Di Leo A, et al: Lactobacillus reuteri strain
combination in Helicobacter pylori infection: A randomized,
double-blind, placebo-controlled study. J Clin Gastroenterol.
48:407–413. 2014.PubMed/NCBI
|
|
196.
|
Pantoflickova D, Corthésy-Theulaz I, Dorta
G, Stolte M, Isler P, Rochat F, Enslen M and Blum AL: Favourable
effect of regular intake of fermented milk containing
Lactobacillus johnsonii on Helicobacter pylori
associated gastritis. Aliment Pharmacol Ther. 18:805–813. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
197.
|
Michetti P, Dorta G, Wiesel PH, Brassart
D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL and
Corthésy-Theulaz I: Effect of whey-based culture supernatant of
Lactobacillus acidophilus (johnsonii) La1 on
Helicobacter pylori infection in humans. Digestion.
60:203–209. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
198.
|
Szajewska H, Horvath A and Piwowarczyk A:
Meta-analysis: The effects of Saccharomyces boulardii
supplementation on Helicobacter pylori eradication rates and
side effects during treatment. Aliment Pharmacol Ther.
32:1069–1079. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
199.
|
Zou J, Dong J and Yu X: Meta-analysis:
Lactobacillus containing quadruple therapy versus standard triple
first-line therapy for Helicobacter pylori eradication.
Helicobacter. 14:97–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
200.
|
Hamilton-Miller JM: The role of probiotics
in the treatment and prevention of Helicobacter pylori
infection. Int J Antimicrob Agents. 22:360–366. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
201.
|
Patel A, Shah N and Prajapati JB: Clinical
application of probiotics in the treatment of Helicobacter
pylori infection - a brief review. J Microbiol Immunol Infect.
47:429–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
202.
|
Shane AL, Cabana MD, Vidry S, Merenstein
D, Hummelen R, Ellis CL, Heimbach JT, Hempel S, Lynch SV, Sanders
ME and Tancredi DJ: Guide to designing, conducting, publishing and
communicating results of clinical studies involving probiotic
applications in human participants. Gut Microbes. 1:243–253. 2010.
View Article : Google Scholar : PubMed/NCBI
|
